YU311676A - Process for obtaining pharmacologically active compounds - Google Patents

Process for obtaining pharmacologically active compounds

Info

Publication number
YU311676A
YU311676A YU03116/76A YU311676A YU311676A YU 311676 A YU311676 A YU 311676A YU 03116/76 A YU03116/76 A YU 03116/76A YU 311676 A YU311676 A YU 311676A YU 311676 A YU311676 A YU 311676A
Authority
YU
Yugoslavia
Prior art keywords
active compounds
pharmacologically active
obtaining
obtaining pharmacologically
compounds
Prior art date
Application number
YU03116/76A
Other languages
English (en)
Inventor
H T Brown
U G Durant
R C Ganellin
Original Assignee
Kline Smith French Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kline Smith French Lab Ltd filed Critical Kline Smith French Lab Ltd
Publication of YU311676A publication Critical patent/YU311676A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU03116/76A 1975-12-29 1976-12-22 Process for obtaining pharmacologically active compounds YU311676A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (1)

Publication Number Publication Date
YU311676A true YU311676A (en) 1983-01-21

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
YU03116/76A YU311676A (en) 1975-12-29 1976-12-22 Process for obtaining pharmacologically active compounds

Country Status (37)

Country Link
JP (1) JPS5283388A (hu)
AR (1) AR222290A1 (hu)
AT (1) AT360024B (hu)
AU (1) AU508123B2 (hu)
BE (1) BE849810A (hu)
BG (1) BG29722A3 (hu)
CA (1) CA1073458A (hu)
CH (1) CH631981A5 (hu)
CS (1) CS203995B2 (hu)
DD (1) DD128588A5 (hu)
DE (1) DE2658267A1 (hu)
DK (1) DK587076A (hu)
EG (1) EG12439A (hu)
ES (1) ES454656A1 (hu)
FI (1) FI62668C (hu)
FR (1) FR2336935A1 (hu)
GR (1) GR62441B (hu)
HU (1) HU175171B (hu)
IE (1) IE45082B1 (hu)
IL (1) IL51040A (hu)
IT (2) IT1124740B (hu)
LU (1) LU76481A1 (hu)
MW (1) MW5076A1 (hu)
MX (1) MX5119E (hu)
NL (1) NL7614538A (hu)
NO (1) NO146396C (hu)
NZ (1) NZ182759A (hu)
OA (1) OA05526A (hu)
PH (1) PH14723A (hu)
PL (1) PL104376B1 (hu)
PT (1) PT65949B (hu)
RO (1) RO72475A (hu)
SE (1) SE431544B (hu)
SU (1) SU791235A3 (hu)
YU (1) YU311676A (hu)
ZA (1) ZA767198B (hu)
ZM (1) ZM14376A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
IN151188B (hu) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
DE2962542D1 (en) * 1979-04-11 1982-06-03 Smith Kline French Lab Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (hu) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
DK587076A (da) 1977-06-30
PH14723A (en) 1981-11-13
SE431544B (sv) 1984-02-13
NL7614538A (nl) 1977-07-01
DD128588A5 (de) 1977-11-30
CH631981A5 (en) 1982-09-15
NO764370L (hu) 1977-06-30
RO72475A (ro) 1982-10-26
DE2658267A1 (de) 1977-07-07
ZA767198B (en) 1977-11-30
NO146396C (no) 1982-09-22
EG12439A (en) 1979-09-30
ES454656A1 (es) 1977-11-16
NZ182759A (en) 1978-06-02
SE7614620L (sv) 1977-06-30
CS203995B2 (en) 1981-03-31
AT360024B (de) 1980-12-10
AU2097676A (en) 1978-07-06
OA05526A (fr) 1981-04-30
PT65949A (pt) 1977-01-01
ATA960876A (de) 1980-05-15
HU175171B (hu) 1980-05-28
IL51040A0 (en) 1977-02-28
BE849810A (fr) 1977-06-23
GR62441B (en) 1979-04-12
IT1124740B (it) 1986-05-14
PT65949B (pt) 1978-06-15
IL51040A (en) 1980-12-31
BG29722A3 (en) 1981-01-15
IE45082L (en) 1977-06-29
ZM14376A1 (en) 1977-08-22
IE45082B1 (en) 1982-06-16
CA1073458A (en) 1980-03-11
JPS5283388A (en) 1977-07-12
FR2336935A1 (fr) 1977-07-29
JPS6129355B2 (hu) 1986-07-05
FI62668C (fi) 1983-02-10
FR2336935B1 (hu) 1980-03-21
IT7919107A0 (it) 1979-01-05
LU76481A1 (hu) 1977-06-15
FI763664A (hu) 1977-06-30
AR222290A1 (es) 1981-05-15
SU791235A3 (ru) 1980-12-23
NO146396B (no) 1982-06-14
FI62668B (fi) 1982-10-29
PL104376B1 (pl) 1979-08-31
MX5119E (es) 1983-03-24
AU508123B2 (en) 1980-03-13
MW5076A1 (en) 1978-02-08

Similar Documents

Publication Publication Date Title
ZA763652B (en) Pharmacologically active compounds
YU311676A (en) Process for obtaining pharmacologically active compounds
YU39077A (en) Process for obtaining sulfonyl-benzimidazole compounds
YU140576A (en) Process for obtaining nifamycin compounds
YU283676A (en) Process for preparing biologically active compounds
PT65590A (en) Pharmacologically active compounds
ZM9876A1 (en) Pharmacologically active compounds
YU144282A (en) Process for obtaining symmetric bis-carbamoyl-sulfide compounds
YU100676A (en) Process for obtaining piperazinylpyrazine
ZA7682B (en) Pharmacologically active compounds
ZA765331B (en) Novel pharmaceutically active compounds
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
GR61114B (en) Process for the production of pharmacologically active compounds
ZA761324B (en) Pharmaceutically active compounds
ZA763837B (en) Pharmacologically active compounds
YU121176A (en) Process for obtaining rifamcin compounds
ZA762536B (en) Pharmacologically active compounds
ZA766778B (en) Pharmacologically active compounds
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
YU11476A (en) Process for obtaining 6-alkoxy-alpha-carboxy-penicillin
YU130582A (en) Process for obtaining new heterocyclic compounds
EG13240A (en) Process for preparing of pharmacologically active compounds
YU109376A (en) Process for obtaining oxazole-carbamide
YU160476A (en) Process for obtaining gamma-pyrone
YU203376A (en) Process for obtaining pharmacologically useful benzimidazole compounds